|
1
|
Ng SC, Tang W, Ching JY, Wong M, Chow CM,
Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, et al: Incidence and
phenotype of inflammatory bowel disease based on results from the
Asia-pacific Crohn's and colitis epidemiology study.
Gastroenterology. 145:158–165.e2. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rogler G: Where are we heading to in
pharmacological IBD therapy? Pharmacol Res. 100:220–227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Makridakis M, Roubelakis MG and Vlahou A:
Stem cells: Insights into the secretome. Biochim Biophys Acta.
1834:2380–2384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wagner J, Kean T, Young R, Dennis JE and
Caplan AI: Optimizing mesenchymal stem cell-based therapeutics.
Curr Opin Biotechnol. 20:531–536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawada H, Fujita J, Kinjo K, Matsuzaki Y,
Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, et
al: Nonhematopoietic mesenchymal stem cells can be mobilized and
differentiate into cardiomyocytes after myocardial infarction.
Blood. 104:3581–3587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang PY, Zhang BY, Cui S, Qu C, Shao LH,
Xu TK, Qu YQ, Dong LH and Wang J: MSC-derived cytokines repair
radiation-induced intra-villi microvascular injury. Oncotarget.
8:87821–87836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan D, Xie X, Qi P, Yang X and Jin X:
Human mesenchymal stem cell homing induced by SKOV3 cells. Am J
Transl Res. 9:230–246. 2017.PubMed/NCBI
|
|
8
|
Xinaris C, Morigi M, Benedetti V, Imberti
B, Fabricio AS, Squarcina E, Benigni A, Gagliardini E and Remuzzi
G: A novel strategy to enhance mesenchymal stem cell migration
capacity and promote tissue repair in an injury specific fashion.
Cell Transplant. 22:423–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bobis-Wozowicz S, Miekus K, Wybieralska E,
Jarocha D, Zawisz A, Madeja Z and Majka M: Genetically modified
adipose tissue-derived mesenchymal stem cells overexpressing CXCR4
display increased motility, invasiveness, and homing to bone marrow
of NOD/SCID mice. Exp Hematol. 39:686–696.e4. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trotta T, Di Gioia S, Piro D, Lepore S,
Cantatore S, Porro C, Castellani S, Petrella A, Fortunato F,
Maffione AB and Conese M: Effect of acute lung injury on VLA-4 and
CXCR4 expression in resident and circulating hematopoietic
stem/progenitor cells. Respiration. 85:252–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ratajczak MZ, Kim CH, Abdel-Latif A,
Schneider G, Kucia M, Morris AJ, Laughlin MJ and Ratajczak J: A
novel perspective on stem cell homing and mobilization: review on
bioactive lipids as potent chemoattractants and cationic peptides
as underappreciated modulators of responsiveness to SDF-1
gradients. Leukemia. 26:63–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang SK, Shin IS, Ko MS, Jo JY and Ra JC:
Journey of mesenchymal stem cells for homing: strategies to enhance
efficacy and safety of stem cell therapy. Stem Cells Int.
2012:3429682012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen QQ, Yan L, Wang CZ, Wang WH, Shi H,
Su BB, Zeng QH, Du HT and Wan J: Mesenchymal stem cells alleviate
TNBS-induced colitis by modulating inflammatory and autoimmune
responses. World J Gastroenterol. 19:4702–4717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pisano F, Mura M, Ciuffreda MC, Calabrò F,
Lanzo N and Gnecchi M: Optimized lentiviral transduction of human
amniotic mesenchymal stromal cells. Pharmacol Res. 127:49–57. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gnecchi M and Melo LG: Bone marrow-derived
mesenchymal stem cells: Isolation, expansion, characterization,
viral transduction, and production of conditioned medium. Methods
Mol Biol. 482:281–294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
17
|
Scharl M, McCole DF, Weber A, Vavricka SR,
Frei P, Kellermeier S, Pesch T, Fried M and Rogler G: Protein
tyrosine phosphatase N2 regulates TNFα-induced signalling and
cytokine secretion in human intestinal epithelial cells. Gut.
60:189–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boyd AS and Fairchild PJ: Approaches for
immunological tolerance induction to stem cell-derived cell
replacement therapies. Expert Rev Clin Immunol. 6:435–448. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Castelo-Branco MT, Soares ID, Lopes DV,
Buongusto F, Martinusso CA, do Rosario A Jr, Souza SA, Gutfilen B,
Fonseca LM, Elia C, et al: Intraperitoneal but not intravenous
cryopreserved mesenchymal stromal cells home to the inflamed colon
and ameliorate experimental colitis. PLoS One. 7:e333602012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ponomaryov T, Peled A, Petit I, Taichman
RS, Habler L, Sandbank J, Arenzana-Seisdedos F, Magerus A, Caruz A,
Fujii N, et al: Induction of the chemokine stromal-derived factor-1
following DNA damage improves human stem cell function. J Clin
Invest. 106:1331–1339. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu H, Liu S, Li Y, Wang X, Xue W, Ge G
and Luo X: The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic
effects of hypoxia-preconditioned mesenchymal stem cells for renal
ischemia/reperfusion injury. PLoS One. 7:e346082012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goto Y and Ivanov II: Intestinal
epithelial cells as mediators of the commensal-host immune
crosstalk. Immunol Cell Biol. 91:204–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kinnaird T, Stabile E, Burnett MS, Shou M,
Lee CW, Barr S, Fuchs S and Epstein SE: Local delivery of
marrow-derived stromal cells augments collateral perfusion through
paracrine mechanisms. Circulation. 109:1543–1549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sackstein R, Merzaban JS, Cain DW, Dagia
NM, Spencer JA, Lin CP and Wohlgemuth R: Ex vivo glycan engineering
of CD44 programs human multipotent mesenchymal stromal cell
trafficking to bone. Nat Med. 14:181–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ko IK, Kim BG, Awadallah A, Mikulan J, Lin
P, Letterio JJ and Dennis JE: Targeting improves MSC treatment of
inflammatory bowel disease. Mol Ther. 18:1365–1372. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kean TJ, Duesler L, Young RG, Dadabayev A,
Olenyik A, Penn M, Wagner J, Fink DJ, Caplan AI and Dennis JE:
Development of a peptide-targeted, myocardial ischemia-homing,
mesenchymal stem cell. J Drug Target. 20:23–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakase H, Matsuura M, Mikami S, Uza N and
Chiba T: Role of the CXC12-CXCR4 axis and CXCL16 in inflammatory
bowel disease. Intest Res. 10:125–133. 2012. View Article : Google Scholar
|
